Anglo-Swedish pharmaceuticals group AstraZeneca has sold Quorn, a leading brand of vegetarian meat-substitute products, to Montagu Private Equity for £70m (US$115.1m). AstraZeneca put Marlow Foods, which makes and distributes Quorn, up for sale a year ago, when the business was estimated to be worth around £100m, reported the Financial Times.